C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2006
11/29/2006	CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006	CN1286975C High affinity immunoglobulin for human antigen and heterologous tumour for manufacturing thereof
11/29/2006	CN1286973C Histone methyl transferase and its preparing method
11/29/2006	CN1286971C Monoclonal antibody, testing kit including the monoclonal antibody and application
11/29/2006	CN1286535C Adsorbent for eliminating hepatitis C virus, adsorber, and adsorption method
11/29/2006	CN1286527C Anti irritability Specificity Igy and its preparation
11/28/2006	US7141662 Diagnosis using antibodies; culture product
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006	US7141652 Antibodies to PRO1561 polypeptide
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141549 For diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins (SEC and NOV)
11/28/2006	US7141435 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
11/28/2006	US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
11/28/2006	US7141404 Candida kefyr cytosine deaminase
11/28/2006	US7141393 Interleukin-18-receptor proteins
11/28/2006	US7141376 Carrier tests for polycystic kidney disease in the cat
11/28/2006	US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof
11/28/2006	CA2294355C Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins
11/28/2006	CA2226968C Novel monoclonal antibody, and immunological assay of e-d-dimer and e-dd/e complex
11/28/2006	CA2178984C Novel antibody compositions for preparing enriched human hematopoietic cell preparations
11/28/2006	CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism
11/28/2006	CA2026915C Stem cell factor
11/28/2006	CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006	WO2006125201A2 Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
11/23/2006	WO2006125200A2 Method for reducing sepsis or cardiogenic shock associated with myocardial injury
11/23/2006	WO2006124932A2 Kinase peptides and antibodies
11/23/2006	WO2006124886A2 Compositions and methods for assaying herg channel binding
11/23/2006	WO2006124689A2 Combination therapy
11/23/2006	WO2006124668A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system
11/23/2006	WO2006124667A2 Compositions and methods for modulating immune responses
11/23/2006	WO2006124627A2 Methods of treating conditions involving neuronal degeneration
11/23/2006	WO2006124451A2 Anti-il-13 antibodies, compositions, methods and uses
11/23/2006	WO2006124269A2 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
11/23/2006	WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
11/23/2006	WO2006122986A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	WO2006122822A2 High-level expression of recombinant antibody in a mammalian host cell
11/23/2006	WO2006122797A2 Anti-gm-csf antibodies and uses therefor
11/23/2006	WO2006122787A1 Serum albumin binding proteins
11/23/2006	WO2006122723A1 Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections
11/23/2006	WO2006097564A3 Novel soluble epcr protein of non-proteolytic origin and use thereof
11/23/2006	WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006	WO2006090241A3 Method of creating or selecting recombinant genes
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006067465A3 Cancer treatment
11/23/2006	WO2006063067A3 Novel tnf receptor regulatory domain
11/23/2006	WO2006060719A3 Use of endosialin binding proteins to isolate endosialin positive cells
11/23/2006	WO2006055778A3 Immunoglobulin variable region cassette exchange
11/23/2006	WO2006047450A3 Immunoassays for topiramate
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	WO2005081711A3 Monomethylvaline compounds capable of conjugation to ligands
11/23/2006	WO2005070180A3 Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
11/23/2006	US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/23/2006	US20060265782 Novel plant transcribed regions and uses thereof
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264617 Monoclonal antibodies to rna binding protein gw182
11/23/2006	US20060264611 Pancreatic islet transcription factor and uses thereof
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264604 Anti-HBs monoclonal antibody
11/23/2006	US20060263877 Novel megakaryocytic protein tyrosine kinase 1
11/23/2006	US20060263857 Compositions and methods for immunomodulation in an organism
11/23/2006	US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety
11/23/2006	US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
11/23/2006	US20060263852 Asp2
11/23/2006	US20060263847 Compositions and methods for treatment of sever acute respiratory syndrome (sars)
11/23/2006	US20060263846 S. penumoniae antigens
11/23/2006	US20060263835 autoantibodies which recognize extracellular structures of G protein-coupled receptors; autoimmune diseases; Raynaud's syndrome, cardiomyopathy, myocarditis, hypertension
11/23/2006	US20060263834 Functional multi-drug resistance assay
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263817 Genetic polymorphism associated with myocardial infarction and uses thereof
11/23/2006	US20060263816 Compounds and methods for labeling oligonucleotides
11/23/2006	US20060263787 Immunoglobulin-like variable chain binding polypeptides and methods of use
11/23/2006	US20060263775 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd
11/23/2006	US20060263774 Nucleotide sequences, vectors, transformed host cells, polypeptides, antibodies; monocyte/macrophage mediated disorders
11/23/2006	US20060263770 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/23/2006	US20060263768 Matrix screening method
11/23/2006	US20060263765 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
11/23/2006	US20060263383 Prognostic indicator
11/23/2006	US20060263375 Antibody-serum protein hybrids
11/23/2006	US20060263374 Antibodies to treat cancer
11/23/2006	US20060263371 Prognostic indicator
11/23/2006	US20060263370 Prognostic indicator
11/23/2006	US20060263369 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis
11/23/2006	US20060263367 Bispecific antibody devoid of Fc region and method of treatment using same
11/23/2006	US20060263366 Neoplasm specific antibodies and uses thereof
11/23/2006	US20060263365 Method of immunomodulation
11/23/2006	US20060263364 Mammalian chemokines; related reagents
11/23/2006	US20060263363 Anti-interferon gamma antibodies and methods of use thereof
11/23/2006	US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy
11/23/2006	US20060263354 Antibodies to myostatin
11/23/2006	US20060263353 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders
11/23/2006	US20060263349 Pretreatment of a biological sample from an autoimmune disease subject
11/23/2006	US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
11/23/2006	DE10344545B9 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
11/23/2006	CA2609150A1 Compositions, methods and kits for real-time nucleic acid analysis in live cells
11/23/2006	CA2609071A1 Method for reducing sepsis or cardiogenic shock associated with myocardial injury
11/23/2006	CA2609043A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	CA2608873A1 Single domain vhh antibodies against von willebrand factor

1 ... 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 ... 1494